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Abstract: A cyclic naphthalene diimide (cyclic NDI, 1), carrying a benzene moiety as linker 
chain, was synthesized and its interaction with G-quadruplex DNAs of a-core and a-coreTT 
as a human telomeric DNA, c-kit and c-myc as DNA sequence at promoter region, or 
thrombin-binding aptamer (TBA) studied based on UV-VIS and circular dichroism (CD) 
spectroscopic techniques, thermal melting temperature measurement, and FRET-melting 
assay. The circular dichroism spectra showed that 1 induced the formation of different types 
of G-quadruplex DNA structure. Compound 1 bound to these G-quadruplexes with affinities 
in the range of 106–107 M−1 order and a 2:1 stoichiometry. Compound 1 showed 270-fold 
higher selectivity for a-core than dsDNA with a preferable a-core binding than a-coreTT,  
c-kit, c-myc and TBA in the presence of K+, which is supported by thermal melting studies. 
The FRET-melting assay also showed that 1 bound preferentially to human telomeric DNA. 
Compound 1 showed potent inhibition against telomerase activity with an IC50 value of  
0.9 μM and preferable binding to G-quadruplexes DNA than our previously published cyclic 
NDI derivative 3 carrying a benzene moiety as longer linker chain. 
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1. Introduction 
Guanine-rich DNA sequences which mainly originate in important regions of the oncogene 
promoters, telomere, mRNA, ribosomal DNA (rDNA), and thrombin-binding aptamer (TBA) can form 
G-quadruplex structures [1–3]. G-quadruplex DNAs, formed at the telomeric end, can inhibit telomere 
elongation by telomerase, which are activated in 80%–85% cancer cells, leading to inhibition of telomerase 
activity [1,4]. G-quadruplex DNAs is known to be formed at promoter regions of the human oncogene 
that can regulate gene expression at the transcriptional level [3]. DNA aptamers bind to thrombin and 
inhibit thrombin-catalyzed fibrin, resulting in blood clotting [2]. Thus, guanine-rich sequences have 
become a very promising target for the development of new anticancer drugs and therapeutic applications, 
which was attracted a lot of research interest during the last few decades and a few of the resulting 
compounds have entered preclinical or clinical trials [3]. 
It has been reported that guanine-rich oligonucleotides could form G-quadruplexes via Hoogsteen 
hydrogen bonding among four guanine bases arranged in a square planar configuration [4]. G-quadruplex 
DNA shows diverse structural polymorphism; G-quadruplex DNA can be either parallel or antiparallel, 
even both conformations (termed hybrid) in some cases [5,6]. This G-quadruplex DNA can fold as a 
mixture of several different quadruplex forms depending on DNA sequence and extrinsic cation which 
offers a platform to induce and stabilize the quadruplexes by using small organic molecules [5,6]. This 
common structural feature poses challenges for the design of ligands with considerable selectivity toward 
one type of quadruplex over other G-quadruplex structures [6]. 
Small molecules that stabilize the G-rich single-strand DNA overhang into G-quadruplex can be 
considered as potential cancer and therapeutic agents [3]. A number of G-quadruplex-binding small 
molecules have been reported in the last few decades [3,7,8]. Several diverse structural ligands, including 
telomestatin, oxazole, cationic TMPyP4, anthraquinone, perylene, acridine, and ethidium derivatives 
have been investigated to evaluate their ability to interact with G-quadruplex DNA and observe their 
biological functions [3,7,8]. There are a number of macrocyclic structures that have been developed  
in the last few years as G-quadruplexes DNA binding ligands such as BQQ1, telomestain, oxazole, 
porphyrin, etc. [9], which is a well-established technique to improve the development of G-quadruplex 
DNA selective drugs. A common feature of these G-quadruplex-binding molecules is the presence of an 
extended aromatic ring system that allows binding through π-π overlap of terminal G-tetrads [5,9]. Large 
flat aromatic planar molecules stack on G-tetrads and show high binding selectivity [6]. Non-planar 
molecules that stack with G-quadruplexes are very rare and bindings are moderate [6]. Some of these  
G-quadruplex-binders include porphyrin derivatives, oxazoles, perylene derivatives and similar  
systems [10] that have fused π-ring systems within the molecule and showed various binding selectivity 
with the G-quadruplexes’ DNA structure. Nowadays, the researchers are focusing on developing  
G-quadruplex DNA structure-specific and selective binding ligands [6,9] which are important for drug 
development, cancer research and therapeutic application studies. 
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Naphthalene diimides (NDIs) are very potent G-quadruplex-binding ligands with high cellular 
toxicity, which is able to effectively stabilize the terminal G-quartet of a G-quadruplex by stacking 
interactions [11,12]. Over the last few years a number of NDI-based compounds have been developed 
in part by exploiting the available NDI-G-quadruplexes structures [13–21]. In our previous studies, we 
already reported interaction studies of some cyclic NDI derivatives and h-telo 22 G-quadruplex DNA 
which can inhibit telomerase activity at low concentration [10,22]. In our present work, we synthesized 
new compound 1 by cyclization with the linker chain of a tertiary amino group and amide group through 
benzene to compare the binding selectivity with our previously reported compound 3 [10] (Figure 1). 
Compound 1 is expected to show reduced binding to dsDNA and increased binding affinity for  
G-quadruplexes DNA because of its shorter linker substituents. We have also sought to compare the 
binding selectivity among the various structures of G-quadruplex DNA. We have characterized the 
binding selectivity and stability of 1 to G-quadruplexes’ DNA present in the promoter region (c-myc  
and c-kit), thrombin binding aptamer (TBA) and human telomeric region (a-core and a-coreTT) by  
UV-Vis spectroscopy, circular dichroism (CD) spectroscopy, thermal melting studies, TRAP assay and  
FRET-melting assay [23] experiments. 
 
Figure 1. Chemical structures of 1, 2 and 3 (3 taken from [10]). 
2. Results and Discussion 
2.1. UV-Vis Absorption Titration 
To obtain the binding constant and the number of bound molecules for the interaction of 1 and non-cyclic 
naphthalene diimide 2 with different DNA forms such as human telomere (a-core and a-coreTT) [4,24,25], 
promoter region (c-kit and c-myc) [26–28] and thrombin-binding aptamer (TBA) [29,30] their absorption 
spectra were investigated. Figure 2A shows a representative spectrophotometric titration of 1 with human 
telomeric G-quadruplex DNA (a-core) in K+ ion. It shows a maximum absorption at 384 nm. Addition of 
increasing amounts of G-quadruplex DNAs to 1 resulted in large hypochromicities (45%–60%) and a 
noticeable small red shift (3–8 nm) was observed. These spectral features are suggestive of end-staking 
binding rather than groove binding (Supplementary Figure S1). We observed isosbestic points at 392 nm 
and 395 nm of 1 for G-quadruplex DNAs and duplex DNA, respectively. The presence of isosbestic 
points indicated the equilibrium between the bound and free ligand. For comparison, we also investigated 
the interaction of 1 with dsDNA. Upon the addition of increasing amounts of dsDNA to 1, smaller 
hypocromic shifts (25%–30%) and red shifts (2–4 nm) were observed than for G-quadruplexes DNA, 
suggesting this compound is not a good dsDNA binder (Figure 2B). The Scatchard plot representing the 
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binding between 1 and a-core (KCl) is presented in Figure 2C. The Scatchard plot was analyzed by the 
McGhee-von Hippel Scatchard equation [31]. The solid line in Figure 2C represents the best fit of the 
experimental value to the McGhee-von Hippel equation. For dsDNA saturation of binding curves was 
not achieved; therefore, estimation of K values using the Scatchard equation was impossible. However, 
nK values were estimated using the Benesi-Hildebrand method [32]. Ligand binding affinity to dsDNA 
does not depend on the nature of the metal cation, such as sodium and potassium ions. In the presence 
of sodium and potassium ions compound 2 binds to dsDNA approximately 20 times stronger than 1. 
 
Figure 2. Spectral shifts of 5 μM 1 on titration with 0, 1.4, 2.9, 4.4, 5.8, 8.7 and 14 μM  
a-core (A) or 0, 2.0, 5.0, 10, 20, 30, and 40 μM dsDNA (B) in 50 mM Tris-HCl (pH7.4) and 
100 mM KCl. Scatchard plots for binding of 1 to a-core (C) and Benesi-Hildebrand plot for 
binding of 1 to dsDNA (D). 
The intrinsic binding constants (K) of 1 and 2 to G-quadruplexes DNA and dsDNA are summarized 
in Table 1. We already reported that 3 carrying a benzene moiety as longer linker chain showed higher 
binding affinity to either G-quadruplexes DNA or dsDNA than 2 [10]. In our present study, we also 
found similar binding constant trends for G-quadruplexes DNA in the range of 106–107 M−1 with n = 2, 
which are an almost five times higher binding affinity of 1 compared with the non-cyclic derivative 2. 
Comparing with 3 [10], 1 showed almost three times higher binding affinity to a-core and 70 times 
weaker binding to dsDNA. Compound 1 showed approximately 200 higher selectivity to G-quadruplexes 
DNA than the previously reported 3 [10]. The comparison suggests that the shorter cyclic linker chain 1 
showed higher specific binding to G-quadruplex DNAs than the previously reported longer linker chain 
compound 3 [10]. 
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Table 1. Binding parameters and melting temperatures of 1 and 2 with a-core, a-coreTT,  
c-kit, c-myc, TBA and dsDNA. 
DNAs 
1 2 Tm/°C  ∆Tm/°C 
10−6 K/M−1 n 10−6 K/M−1 n DNAs 1 2 
a-core (K+) 10 ± 0.5 a 1.5 1.6 ± 0.2 a 1.4 69 c 15 5 
a-core (Na+) 1.0 ± 0.04 a 2.2 0.73 ± 0.09 a 1.0 57 c - 1 
a-coreTT (K+) 6.1 ± 0.4 a 1.8 1.9 ± 0.3 a 1.3 63.5 c 18 - 
TBA (K+) 3.5 ± 0.2 a 1.4 0.49 ± 0.04 a 1.1 50.5 c 11 - 
c-kit (K+) 1.9 ± 0.18 a 1.4 0.74 ± 0.05 a 1.7 54 d 11 - 
c-myc (K+) 4.0 ± 0.3 a 1.7 1.5 ± 0.2 a 1.6 70 e 15 - 
dsDNA (K+) 0.037 b - 0.60 ± 0.04 a 2.8 49 c 0.3 12 
dsDNA (Na+) 0.037 b - 0.60 ± 0.08 a 3.0 49 c 0.3 12 
Condition: Binding constant (K): 50 mM Tris-HCl (pH 7.4) and 100 mM NaCl or KCl; a: Scatchard analysis (K);  
b: Bensi-Hildebrand analysis (nK); Thermal melting: [ligand]:[DNA] = 2:1, 50 mM Tris-HCl (pH 7.4); c: 100 mM 
NaCl or KCl; d: 20 mM KCl; e: 5.0 mM KCl. 
In comparison with our previous report [10], the linker chain of 1 and 3 may play an important role 
in the binding with G-quadruplexes DNA over dsDNA. The amide chains of 1 and 3 might be more 
effective in reducing binding with dsDNA because of the NDI moiety site blocks the aliphatic chain 
from intercalating in the benzene part. Moreover, the benzene part itself also prevents binding of 1 and 
3 from threading intercalations with dsDNA. However, as we have reported earlier [33], 1 and 3 showed 
affinity to calf thymus DNA (CT-DNA), Poly[d(A-T)]2 and Poly[d(G-C)]2 due to hydrophobic 
interaction between cyclic NDI derivatives and dsDNA. Compound 1 showed lower binding affinity to 
CT-DNA, poly[d(A-T)]2 and poly[d(G-C)]2 than 3 perhaps because of steric reasons, whereas, according 
to the computer modeling, the NDI moiety site of cyclic NDI derivatives incorporated to end staking 
onto the G-quartet. We have observed that 1 showed higher selectivity to G-quartet than 3 because the 
tertiary amino chain in the linker chain of 1 may have more compatibility to bind specifically with the 
G-quartet plane than the piperazine linker chain of 3. 
In the presence of sodium ions the binding affinities of both ligands to basket-type tetraplex structures 
were much lower than G-quadruplexes in potassium solution. We already explained that this might be 
due to the fact that basket type a-core crosses its oligonucleotide chain over the G-quartet diagonally and 
disrupts access of 1 to the G-quartet plane [10]. 
In our present study, all the G-quadruplexes DNA showed higher binding constants (K) with 1 than 
dsDNA. In potassium ion solution, 1 exhibited the highest binding affinity for mixed hybrid type a-core [24] 
with K = 1 × 107 M−1, whereas diminished the binding affinity to dsDNA with nK = 3.7 × 104 M−1. The 
binding data indicated that 1 has a 270-fold preference for a-core over dsDNA. Table 1 shows the binding 
constants (K) are K = 6.1 × 106 M−1 for a-coreTT (hybrid type-2) [25], K = 1.9 × 106 M−1 for c-kit 
(parallel propeller type) [27], K = 4.0 × 106 M−1 for c-myc (parallel type) [27], K = 3.5 × 106 M−1 for 
TBA (antiparallel chair type) [30] with 1, which represent a 165-, 51-, 108- and 95-fold binding 
preference over dsDNA (K = 3.7 × 104 M−1), respectively. The ratio of ligand per dsDNA used for binding 
was n = 3, a reasonable result considering that a typical intercalator covers two base pairs upon binding 
to dsDNA, in addition to the expected relative difficulty in binding at terminal sites. The binding number 
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of a ligand with G-quadruplexes DNA was estimated to be n = 2, which may agree with an end-stacking 
binding of 1 to the external G-quartet planes of quadruplexes. 
According to the above result, new compound 1 showed G-quadruplexes DNA structure-specific 
binding. Compound 1 showed the highest affinity to a-core DNA, which exhibits mixed type hybrid 
(hybrid-1 and hybrid-2) structures in K+ [24] and possessed more than two drugs staking plane and 
binding loops. Computer modeling showed that 1 was stacked and bound to a mixed hybrid structure at 
various G-quadruplex staking planes, whereas a-coreTT exhibited hybrid-2 [25] type structures which 
have two G-tetrads staking planes and two binding sites. For this reason we observed that 1 showed  
the highest affinity with a-core. TBA exhibited an antiparallel chair type [29,30] structure which has  
G-quartet staking planes and binding loops, while c-kit and c-myc exhibited parallel type [27] propeller 
structures which possess two G-quartet staking planes, but binding loops are unusual for 1. According 
to the binding data, new compound 1 was revealed to be a most preferable and specific binder to 
telomeric G-quadruplexes DNA than promoter regions’ G-quadruplex DNA as well as thrombin binding 
aptamer. The binding studies results are consistent with thermal melting studies where a-core showed 
the highest stabilization with 1. The binding site size (n values) obtained from binding studies of  
G-quadruplexes and 1 are consistent with the Job plot analysis from CD studies (Supporting Information 
Figure S2). 
2.2. Circular Dichroism (CD) Studies 
CD is a powerful method to differentiate the parallel, anti-parallel, and mixed-type secondary 
structure of G-quadruplex DNA. Compound 1 was interacted to investigate the effect of the compound 
binding on the conformation of the G-quadruplexes, which is shown in Figure 3. The CD spectrum of 
human telomere (a-core) G-quadruplex DNA showed a negative peak at 240 nm, a shoulder peak at 265 nm 
and a positive peak at 290 nm (Figure 3A) in buffer containing 100 mM KCl, supportive of a mixed 
hybrid type (hybrid-1 and hybrid-2) G-quadruplex structure [34,35]. The small positive peak at 265 nm 
was transformed increasingly into a negative peak at 260 nm together with an increase of the positive 
peak at 290 nm upon the addition of 1, suggesting the induction of a hybrid type structure. After addition 
of 1, a-core structure conformation changed a little from mixed hybrid type to hybrid-1 type [36]. In our 
previous study, we reported that in the presence of Na+ ions, telomeric DNA exists in an antiparallel 
basket-type conformation. Upon addition of 1, this antiparallel basket-type structure was also retained [10]. 
The CD spectrum of human telomere (a-coreTT) G-quadruplex in buffer containing 100 mM KCl 
exhibits a negative peak at 240 nm, a shoulder peak at 265 nm and a positive peak at 290 nm (Figure 3B) 
supportive of a hybrid-2 type G-quadruplex structure [34,35]. The small positive peak at 265 nm is 
transformed increasingly into a negative peak at 260 nm together with an increase of the positive peak 
at 290 nm upon the addition of 1, suggesting the induction of a hybrid type structure. After the addition 
of 1, a-core structure conformation changed a little from hybrid-2 type to hybrid-1 type [36]. 
In the presence of 100 mM KCl thrombin-binding aptamer (TBA, Figure 3C) exhibited a positive 
peak at 290 nm, and a negative band at 250 nm, supportive of an anti-parallel chair type G-quadruplex 
structure [30,37]. Upon the addition of 1, the negative peak transformed increasingly into at 260 nm 
together with an increase of the positive peak at 290 nm, suggesting that the binding of 1 apparently does 
not disturb the structure of TBA, which is consistent with previous reports [37]. 
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Figure 3. CD spectra of 1.5 μM of a-core (A); a-coreTT (B); TBA (C); c-kit (D); c-myc (E) 
in 50 mM Tris-HCl (pH 7.4), 100 mM KCl in addition of 1 (0, 0.38, 0.75, 0.80, 2.25, and 
3.00 μM) at 25 °C.  
Both c-myc and c-kit G-quadruplex (Figure 3D,E) exist in the presence of K+ ions as a parallel 
structure, which has a characteristic positive peak centered around 262 nm, a negative peak at 241 nm 
and a small shoulder peak at 290 nm [38,39]. After the addition of 1 to c-myc and c-kit G-quadruplex, a 
decrease of the CD peaks at 241 nm and 262 nm was observed, with no other significant change in the 
spectrum and the parallel structure was not change, which suggests ligand-dependent disruption of 
staking of G-quadruplex DNA. Upon the addition of 1, the c-kit structure shoulder peak at 290 nm 
increased little. This effect has also been observed previously by many research groups [40]. 
The Job plot analysis by CD studies (Supporting Information Figure S2) showed that CD studies  
of G-quadruplexes and 1 are consistent with binding studies where similar binding site sizes (n values)  
are obtained.  
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2.3. Thermal Melting Studies 
Thermal stabilization of various G-quadruplexes DNA and dsDNA in the presence of 1 was studied 
using the CD melting and UV-Vis melting experiment (Figure 4). Thermal melting of hybrid type 
telomeric quadruplex DNA (a-core and a-coreTT) was monitored at 290 nm in the presence of K+ [25].  
 
Figure 4. Melting profiles for a-core (A); a-coreTT (B); TBA (C); c-kit (D); c-myc (E) in the 
absence or presence of 1 in 50 mM Tris-HCl (pH 7.4); 100 mM KCl (A–C); 20 mM KCl (D); 
5.0 mM KCl (E) and [ligand]:[DNA] = 2:1. 
The Tm value was observed around 69 °C for a-core without 1 (Figure 4A). We observed that the 
interaction of 1 with telomeric DNA quadruplex enhanced the stability by 15 °C for a-core and 18 °C 
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for a-coreTT, which was approximately 3 °C higher for a-coreTT than a-core G-quadruplexes  
DNA (Table 1). Researchers already reported that thermal melting increased after addition of base to 
oligonucleotides [41]. In our previous report [10], we observed from the absorption spectra that 3 had the 
lowest binding affinity to a-core in sodium ion solution. Furthermore, dsDNA was monitored by  
UV-Vis melting studies. After the addition of a 1-fold 1 concentration, only a slight increase (up to  
0.3 °C) in thermal stability was observed (Table 1 and Supplementary Figure S3). These results 
underscore the fact that 1 selectively stabilizes telomeric quadruplex DNA as well as promoter and thrombin 
binding aptamer G-quadruplex DNA over dsDNA. In comparison with our previous report [10], 
compound 1 showed high stabilizing effect to a-core and very weak stabilizing effect to ds DNA. 
The melting temperatures of antiparallel chair type thrombin binding aptamer quadruplex DNAs 
(TBA) were monitored at 290 nm. Compound 1 increased the Tm of TBA by 11 °C (Table 1). These 
results are consistent with previously published articles [30,37]. The melting temperatures of parallel 
promoter quadruplex DNAs such as c-kit and c-myc were monitored at 263 nm [39,40]. In the case of 
the highly stable parallel c-kit and c-myc quadruplex DNA was highly stable at high salt concentration 
and a stable baseline curve was not achieved even above 90 °C, so it is not possible to measure an 
accurate Tm in this case, so we measured Tm for c-kit and c-myc at low salt concentration. Compound 1 
increased the Tm of c-kit by >11 °C at 20 mM K+ ion and the Tm of c-myc by >15 °C at 5 mM K+ ion 
solution (Table 1). This type of performance of c-kit and c-myc is consistent with previously published 
articles [39,40]. According to the above result, we can conclude that 1 preferably stabilizes telomeric 
quadruplex DNA than promoter and thrombin binding aptamer G-quadruplex DNA. CD melting results 
are consistent with binding and competition assay studies, where 1 showed preferable binding to human 
telomeric G-quadruplex. 
2.4. TRAP Assay 
Once the G-quadruplexes DNA stabilization was established for 1, it was important to test whether 
the molecule inhibits telomerase activity. To evaluate the abilities of these compounds to inhibit 
telomerase, the telomeric repeat amplification protocol (TRAP assay) [10,22] was carried out using 
various amounts of 1 (Figure 5). The assay clearly shows that 1 is a potent inhibitor of telomerase with 
activity in the submicromolar range (IC50) 0.9 μM. This result suggests that the TS-primer extends the 
length to form a tetraplex structure and 1 binds to it and stabilizes its structure to inhibit the telomerase 
reaction. The values obtained from the TRAP assay are comparable to those of previously reported 
derivatives [10,22]. A number of small ligands have been discovered to inhibit the function of telomerase 
by stabilizing G-quadruplexes DNA structures [7]. The excellent IC50 for telomerase inhibition by 1  
(0.9 μM) comes from its binding constant (K > 107 M−1). It is suggested that this macrocyclic compound 
1 may deserve biological assays with cancer cell lines to represent a suitable candidate drug target to 
DNA quadruplexes. 
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Figure 5. Telomerase inhibition by 1. The gel shows the effect of increasing concentrations 
of 1 (0, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0, 3.0, 4.0 μM) on telomerase activity. Concentrations of 
2.0–4.0 μM 1 lead to the disappearance of all PCR products. IC50s were determined as 
follows: ligand concentration under half telomerase activity with no ligand. 
2.5. FRET-Melting Assay 
The sequence and structural selectivity of different DNA binding agents has been previously explored 
by use of a thermodynamically rigorous competition assay procedure introduced by Ren and Chaires [23,42]. 
In this method, different nucleic acid structures are assayed against a common ligand solution. This is a 
simple method to evaluate specificity toward quadruplexes [43]. It has been already reported that F21T 
showed a Tm value around 50 °C [23] that increased by 11 °C after incorporation of 1 with F21T. 
Comparison with other G-quadruplexes DNA is shown in Figure 6. Compound 1 displays a strong 
preference for binding to F21T quadruplex structure which corresponds to the human telomeric G-rich 
motif than other quadruplexes DNA structures. 
 
Figure 6. FRET-melting assay of human telomeric DNA (a-coreTT) (1.0 or 3.0 μM), 
promoter region’s DNA (c-kit & c-myc) (1.0 or 3.0 μM) and thrombin-binding aptamer 
(TBA) (1.0 or 3.0 μM) with F21T (0.2 μM) in the presence of 1 (0.4 μM). Experiments were 
performed at 25 °C in 100 mM Tris-HCl buffer pH 7.4 containing 150 mM KCl. 
0
0.2
0.4
0.6
0.8
1
0 0.5 1 1.5 2 2.5
N
or
m
al
iz
ed
Te
lo
m
er
as
e
ac
tiv
ity
[1] / M
Molecules 2015, 20 10973 
 
 
2.6. Computer Modeling 
The computer-modeling structures consisting of 1 with mixed hybrid types G-quadruplex DNA (a-core) 
are shown in Figure 7. In this article we proposed a model involving an end staking binding mode 
between 1 and mixed hybrid types G-quadruplex DNA (a-core), which are consistent with our previously 
published article [22]. The computer modeling showed that the 1 molecule stacked and bound to different 
G-quartet plane of mixed hybrid types G-quadruplex DNA (a-core). 
 
Figure 7. Computer modeling of 1 interaction with mixed hybrid G-quadruplex DNA structure (A–C). 
3. Experimental Section 
3.1. Materials 
The seven G-rich oligonucleotides: a-core (5′-AGGG(TTAGGG)3-3′), a-coreTT (5′-AGGG 
(TTAGGG)3TT-3′), TBA (5′-GGTTGGTGTGGTTGG-3′), c-kit (5′-AGGGAGGGCGCTGGGAG 
GAGGAGGG-3′), c-myc (5′- TGAGGGTGGGGAGGGTGGGGAA-3′) and dsDNA composed of two 
complementary strands: (5′-GGGAGGTTTCGC-3′) and (5′-GCGAAACCTCCC-3′) were purchased 
from Genenet Co. (Fukuoka, Japan) and used without further purification. The following extinction 
coefficients were used for quantification of nucleic acid solutions (unit of ε was M−1 cm−1): 114,000 for 
5′-GGGAGGTTTCGC-3′; 108,600 for 5′-GCGAAACCTCCC-3′; 228,500 for a-core (5′-AGGG 
(TTAGGG)3-3′); 245,100 for a-coreTT (5′-AGGG(TTAGGG)3TT-3′); 143,300 for TBA (5′-GGTTG 
GTGTGGTTGG-3′); 260,100 for c-kit (5′-AGGGAGGGCGCTGGGAGGAGGAGGG-3′); 229,900 for 
c-myc (5′-TGAGGGTGGGGAGGGTGGGGAA-3′). Before use, oligonucleotide solutions in  
50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl or KCl were heated to 95 °C and annealed 
by slowly cooling to room temperature. Guanine-rich telomere oligonucleotide sequence  
(5′-d-GGGTTAGGGTTAGGGTTAGGG3′), dual label with FAM (fluorescent donor) and TAMRA 
(fluorescent acceptor) at the 5′ and 3′ end, called ‘F21T’, respectively, were purchased from  
Sigma-Aldrich (St. Louis, MO, USA). The synthesis procedure of 1 was described in detail in a previous 
article [33]. Compound 2 was synthesized as described previously [44]. The 2.0 M KCl, and 5.0 M NaCl 
aqueous solutions were obtained from Life Technologies (Carlsbad, CA, USA). 1.0 M Tris-HCl  
(pH 7.4) buffer was obtained from Sigma-Aldrich. GoTaq Hot Start polymerase was purchased from 
Promega (Madison, WI, USA). TRAPese kit was obtained from EMD Millipore (Billerica, MA, USA). 
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3.2. UV-Vis Titration Experiments 
Absorption spectra were measured on a U-3310 spectrophotometer (Hitachi, Tokyo, Japan) with a 1 
cm path-length quartz cell and were recorded in the 200–600 nm range at 25 °C. UV-Vis absorption 
titrations were carried out by the stepwise addition of 200 μM/strand of G-quadruplexes DNA or dsDNA 
solution to a UV-cell containing 5.0 μM solutions of 1 or 2. The measurements were performed in a  
50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl or KCl. Binding data obtained from 
spectrophotometric titration of increasing concentrations of drug to a fixed concentration of DNA was 
cast into the form of a Scatchard plot of ν/C against ν. The Scatchard plot was analyzed by the Scatchard 
equation: ν/C = K(n–ν) [31], where ν is the stoichiometry (the number of ligand molecules bound per 
moles of base pair), C is the free ligand concentration, K is the observed binding constant, and n is the 
number of base pairs excluded by the binding of a single ligand molecule. For duplex oligonucleotides 
saturation of binding curves was not achieved, so K values were estimated using Benesi-Hildebrand 
method 1/ΔAbs = 1/(lΔε [ligand]) + 1/(nKlΔε [ligand]) × (1/DNA) [32] with the assumption that the 
ligand/oligonucleotide complex with 1:1 stoichiometry is formed (Table1), where Δε is a molar 
absorptivity change of ligand and l is 1 cm. Scatchard plots were prepared using absorption changes at the 
specific wavelength 383 nm upon the addition of various concentrations of dsDNA. Scatchard plots were 
prepared using the data in a range of approximately 30%–80% bound region of 1 and dsDNA. The 
binding data were analyzed with KaleidaGraph software, using the Levenberg-Marquardt algorithm to 
determine parameters Kb and n. 
3.3. Circular Dichroism (CD) Spectral Measurements 
Various concentrations (5.0 to 50 μM) of 1 or 2 were added to 1.5 μM/base pair G-quadruplexes DNA 
in a 50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl or KCl at 25 °C, and CD spectra taken 
at a scan rate 50 nm/min on a J-820 spectropolarimeter (Jasco, Tokyo, Japan). Other conditions were: 
response 2 s, data interval 0.1 nm, sensitivity 100 mdeg, band width 2 nm, and scan number 4 times.  
3.4. Thermal Melting Experiments 
Melting curves of G-quadruplexes DNA or dsDNA were measured on a Hitachi 3300 spectrophotometer 
(heating rate of 0.5 °C/min to 90 °C) or Jasco J-820 spectrophotometer (response, 100 mdeg; response, 
8 s; data collecting interval, 0.5 °C; bandwidth, 2 nm) equipped with a temperature controller, 
respectively. The melting curves based on circular dichroism (CD) at 290 nm of a-core, a-coreTT, and 
TBA, 262 nm of c-kit and c-myc or 260 nm of dsDNA were measured in 50 mM Tris-HCl (pH 7.4) 
containing 100 mM NaCl or KCl (for c-kit 20 mM KCl and for c-myc 5 mM KCl). A mixture of 1.5 μM 
a-core, a-coreTT, TBA, c-kit, c-myc, dsDNA and 3.0 μM of 1 or 2 was placed in a cell of 1 cm in light 
path length (total 3 mL). Ligand-DNA ratio was set at 2:1. 
3.5. TRAP Assay Experiments 
Telomeric repeat amplification protocol (TRAP) assay was performed using published procedure [10,22]. 
TRAPeze Telomerase Detection Kit from EMD Millipore was used. Briefly, TS forward primer was 
elongated by telomerase in TRAP buffer (20 mM Tris-HCl pH 8.3, 1.5 mM MgCl2, 63 mM KCl, 0.05% 
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Tween 20, 1.0 mM EGTA) containing 0.05 mM dNTPs, 0.4 μM TS primer, 0.4 μM primer Mixed (RP 
primer, K1 primer, TSK1 primer) and 2.0 units of GoTaq Hot Start polymerase. The mixture was added 
to freshly prepared 1 solution from 0.1 to 4.0 μM (0, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0, 3.0, 4.0 μM) and a 
positive control containing no ligand. Firstly, the elongation step was carried out for 60 min at 30 °C and 
it was followed by 5 min incubation at 95 °C. Secondly, 35 cycles of PCR were performed (94 °C, 30 s; 
62 °C, 1 min; 72 °C, 1 min). Telomerase extension products were analyzed on a denaturing 12.5% 
polyacrylamide vertical gel prepared in 5 × TBE buffer (89 mM Tris base, 89 mM borate, and 1 mM 
EDTA, pH 8.0). The electrophoresis was run in 0.7 × TBE buffer for 2 h at 200 V. After electrophoresis 
gel was stained in 1 × GelStar Nucleic Acid Stain (Takara Bio, Shiga, Japan) in 1× TBE buffer for  
30 min and photographed. 
3.6. FRET-Melting Assay 
Fluorescence-based melting competition assays was performed using a previously published  
procedure [23]. In more recent experiments, a real-time PCR apparatus (MX3000P, Stratagene, La Jolla, 
CA, USA; or Sigma-Aldrich SYBR Green or DNA engine Opticon, MJ Research, Waltham, MA, USA) 
is used, allowing the simultaneous recording of 32–96 independent samples as first proposed by S. Neidle 
and co-workers [23]. The protocol used for our experiments is the following: a first step of equilibration 
at the lowest temperature (5 min at 25 °C) and a stepwise increase of 1 °C every minute for 72 cycles to 
reach 95 °C. The buffer 100 mM Tris-HCl (pH 7.4) containing 150 mM NaCl or KCl and 0.4 μM 1 was 
used for all experiments. The thermal denaturation profile of the oligonucleotide F21T (0.2 μM) and  
G-quadruplexes DNA (a-coreTT, TBA, c-kit and c-myc) (1.0 or 3.0 μM) were measured in the presence 
of 1 (0.4 μM). The ratio of F21T and G-quadruplexes DNA was used 1:5 or 1:15 at 0.4 μM 1. 
Fluorescence-based melting assays competition measurements were performed with F21T dual label 
with FAM (fluorescent donor) and TAMRA (fluorescent acceptor) at the 5′ and 3′ end from Sigma-Aldrich 
at a heating rate of 1 °C/min. The recording is performed after 1 min stabilization. Typically three replicate 
experiments were performed, and average values are reported. Finally, the amount of ligand bound to the 
DNA was quantified by fluorescence after the digestion of the oligonucleotide (λex and λem were set to 
490 and 520 nm for oligonucleotides, respectively). 
3.7. Computer Modeling 
Molecular modeling of these complexes was constructed by MOE 2011.10 
(http://www.chemcomp.com/). Compound 1 was placed on the binding site of mixed hybrid types  
G-quadruplex DNA (a-core) and energy minimization of these complexes was carried out. The 
molecular dynamics calculation of these mineralized complexes was further carried out until 1 was 
located in the binding site as stable condition. Finally, energy minimization of the complexes was 
obtained as shown in Figure 7. These calculations were used the force field of MMFF94x. 
4. Conclusions 
We have a synthesized new type of ligand 1, carrying a benzene moiety as linker chain and studied its 
interaction with different types of G-quadruplexes DNA. We have compared this study with our 
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previously reported 3 [10] which has a long linker chain than 1. Compound 1 exhibited high binding 
affinity in the range of 106–107 M−1 to G-quadruplexes DNA and reduced binding affinity to dsDNA. 
The binding data (Table 1) indicated that 1 has 270-fold preferential binding for a-core, 165-fold for  
a-coreTT, 51-fold for c-kit, 108-fold for c-myc, 95-fold for TBA over dsDNA. The binding 
stoichiometry of 1 for G-quadruplex is 2:1, suggesting a staking binding mode. Compound 1 revealed 
200-fold higher binding selectivity compared with our previously reported 3 [10]. We have observed 
that 1 revealed preferable binding to mixed hybrid types structure of telomeric G-quadruplex DNA  
(a-core) over parallel types of promoter region’s G-quadruplex DNA (c-kit and c-myc) and antiparallel 
chair types of thrombin binding aptamer (TBA). The CD spectra showed that 1 stabilized  
G-quadruplexes DNA structure. Upon the addition of 1 to a-core the CD spectra showed little change 
indicating a mixed hybrid structure and little changed to the hybrid-1 type G-quadruplex structure [36]. 
Thermal melting measurements indicated that 1 highly stabilized the G-quadruplexes DNA structure. 
Compared with our previous report [10], 1 increased ∆Tm by 5–8 °C. We have performed competitive 
assays in order to determine the binding selectivity among the G-quadruplexes DNA, and 1 showed highly 
preferable stabilization of human telomeric G-quadruplex sequence (F21T). This novel compound 1 can 
also inhibit the telomerase activity at low submicromolar concentration. These results indicated that 1 is 
an important class of G-quadruplex stabilizing ligand compared with dsDNA. 
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